title: Efficacy of delayed percutaneous transluminal coronary angioplasty after intravenous use of streptokinase in myocardial infarction.
abstract: Between June 1984 and December 1986, 35 patients with acute myocardial infarction received streptokinase intravenously within 3 hours after the beginning of chest pain and underwent percutaneous transluminal coronary angioplasty (PTCA) either immediately (in 2 cases) or 1 to 19 (mean 4.4) days later (in 33). The rate of successful PTCA was 89%. Reocclusion occurred in one patient. The mean percentage of stenosis decreased from 86% to 11%. The mean trans-stenotic gradient was reduced from 41 to 11 mm Hg. The results suggest that in patients whose condition is stable, PTCA performed a few days after thrombolysis is a valuable alternative to more aggressive treatment with immediate PTCA.
authors.affiliation: Department of Medicine, University of Montreal, Notre-Dame Hospital.
authors.forename: R M
authors.initials: RM
authors.lastname: Gagnon
authors.forename: M
authors.initials: M
authors.lastname: Morissette
authors.forename: P
authors.initials: P
authors.lastname: Laramée
authors.forename: G
authors.initials: G
authors.lastname: Dumont
authors.forename: F
authors.initials: F
authors.lastname: Sestier
authors.forename: G
authors.initials: G
authors.lastname: Leclerc
authors.forename: E
authors.initials: E
authors.lastname: Goudreau
mesh_terms: D000368:Aged; D000800:Angioplasty, Balloon; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D011379:Prognosis; D011446:Prospective Studies; D012008:Recurrence; D013300:Streptokinase / Q000008:administration & dosage*; D013997:Time Factors; D014654:Vascular Patency
chemical_list: D013300:Streptokinase